4//SEC Filing
KANAN MICHAEL F 4
Accession 0001567619-19-006615
CIK 0001012477other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 7:10 PM ET
Size
12.7 KB
Accession
0001567619-19-006615
Insider Transaction Report
Form 4
KANAN MICHAEL F
See Remarks
Transactions
- Award
ADSs
2019-03-07+18,000→ 50,538 total - Award
Stock Option (right to buy)
2019-03-07$1.85/sh+80,000$148,000→ 80,000 totalExercise: $1.85Exp: 2029-03-07→ ADSs (80,000 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $16.21Exp: 2025-10-28→ ADSs (100,000 underlying) - 80,000
Stock Option (right to buy)
Exercise: $8.95Exp: 2027-12-12→ ADSs (80,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $10.40Exp: 2026-12-14→ ADSs (100,000 underlying)
Footnotes (7)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes (a) 18,000 ADSs granted under the issuer's "Free Share" award program as restricted ADSs on 12/14/2016, all of which were issued to the reporting person on the second anniversary of the grant date; in connection with the payment of certain withholding taxes related to such issuance, the reporting person sold 8,429 ADSs on December 14, 2018; (b) 18,000 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, of which 12,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 6,000 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant); (c) 3,000 ADSs acquired under the issuer's 2017 Employee Share Purchase Plan on 1/8/2019; and [continued in footnote 3 below]
- [F3](d) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 3/7/2019, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary).
- [F4]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 10/28/2015 grant date.
- [F5]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- [F6]Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
- [F7]Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 3/7/2019 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001461953
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 7:10 PM ET
- Size
- 12.7 KB